Tag: China
-
Infographic – China, India Continue as Top Student Sources
China and India provided more than half of all international students at U.S. universities in the last academic year, as total enrollment from overseas approached pre-pandemic levels.
-
Infographic – Planned Moon Missions Through 2030
The Jaxa space agency from Japan plans a landing later this year, while NASA from the U.S. also expects to launch an orbital mission to the moon this year.
-
Infographic – Chinese Companies Lead in A.I. Patents
Data in the chart are compiled by PatentSight, a service of LexisNexis, that show the seven leading holders of machine learning and other A.I. patents by company in 2017 and 2021.
-
Venture to Build Cell, Gene Therapy Businesses
A joint venture with business development and bio-manufacturing companies aims to build new cell and gene therapy businesses to advance treatments from Mayo Clinic labs.
-
AI Analytics Find New ALS Genetic Drug Targets
Researchers analyzed medical and scientific databases with algorithms to identify eight previously unreported biomarkers contributing to neurodegeneration similar to ALS.
-
Clinical Trial Set for AI-Driven Lung Fibrosis Drug
A clinical trial is set to begin testing the safety and chemical activity of a drug candidate for lung fibrosis, discovered and refined with artificial intelligence.
-
Trial Shows Immunotherapy Improves Lung Cancer Survival
Clinical trial results show an immunotherapy licensed as a lower-priced cancer drug increases survival time in combination with chemotherapy.
-
AI Process Discovers, Tests Fibrosis Drug in 18 Months
A provider of drug discovery services based on artificial intelligence says in 18 months it identified and tested in mice a new drug for a chronic lung disease.
-
Large Trial Testing Covid-19 Antibody Therapies
A clinical trial conducted by National Institutes of Health is evaluating two more synthetic antibodies as treatments for patients hospitalized with Covid-19 infections.
-
AbbVie Acquires Coronavirus Antibody Therapy
Drug maker AbbVie is licensing a synthetic antibody to treat Covid-19 and SARS coronaviruses that the company began funding in June.